This is the authors' abstract. We don't add key points for this paper.
We describe herein the results of our studies related to the application of X-ray crystallography, the Thorpe-Ingold effect, deuteration, and stereochemistry in the design of highly potent and non-toxic inhibitors of SARS-CoV-2 3CLpro to combat SARS-CoV-2 and emerging variants.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dampalla et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: